Case Studies

Harnessing Targeted Protein Degradation

Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.

Company Logo

Released By Syngene International Ltd.

One of the leading biotech companies working in the targeted protein degradation was looking for partners to help them scale quickly. The key criteria they set out were fast delivery of the compounds, ability to quickly solve chemistry problems, open, transparent and on-time communication and flexibility and ability to scale. The key challenge was the novelty of the modality, with very few companies having expertise in this space.

DOWNLOAD TO LEARN MORE>>>>

Download Case Studies Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters